logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
24/04/2026
Sinembex expects that after the conflict ends, the prices of bulk liquid commodities will remain above the levels before the conflict.
Latest
5 m ago
Donghua Energy: It is expected to have a net loss of 944 million to 984 million yuan in 2025.
6 m ago
Before the market opened, Lilly's US stocks fell nearly 4% while Novo Nordisk rose over 2%. According to the latest prescription data, Lilly's new weight loss drug, Foundayo, had a slow start after its launch. This is an early sign that the company will face challenges in trying to catch up with the competitor Novo Nordisk. Canadian Royal Bank Capital Markets analyst Trung Huynh cited data from IQVIA, stating that Foundayo only had 3,707 prescriptions in its second week on the market. In comparison, Novo Nordisk's oral version of Wegovy had a total of 18,410 prescriptions in its second week on the market.
6 m ago
The emerging markets foreign exchange index rose during the day as hopes were rekindled for negotiations between Iran and the United States.
6 m ago
Guangge Technology: Net loss of 4.5214 million yuan in the first quarter of 2026.
7 m ago
Meta Platforms (META.O) and Amazon (AMZN.O) have reached a multi-billion dollar agreement which will take effect in the coming years. According to the agreement, the social media company will use tens of millions of Amazon Web Services (AWS) Graviton core chips to support its artificial intelligence agents and other AI plans. Amazon vice president Bashara stated that the deal will last for three to five years and most of the tens of millions of AWS Graviton cores will be located in the United States.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.